About Linus Biotechnology
Linus Biotechnology is a company based in New York (United States) founded in 2020 by Paul Curtin and Christine Austin. Linus Biotechnology has raised $47.65 million across 4 funding rounds from investors including Yac, GreatPoint Ventures and BowX Acquisition Corp. Linus Biotechnology operates in a competitive market with competitors including Genomics, Depixus, Seven Bridges Genomics, Ingenuity Systems and BC Platforms, among others.
- Headquarter New York, United States
- Founders Paul Curtin, Christine Austin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$47.65 M (USD)
in 4 rounds
-
Latest Funding Round
$6.15 M (USD), Series A
Jul 29, 2024
-
Investors
Yac
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Linus Biotechnology
Unlock access to complete
Funding Insights of Linus Biotechnology
Linus Biotechnology has successfully raised a total of $47.65M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $6.15 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Linus Biotechnology
Linus Biotechnology has secured backing from 5 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Yac, GreatPoint Ventures and BowX Acquisition Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on early-stage big data, health tech, AI, food tech, and multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital firm linking startups to University of California networks.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Linus Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Linus Biotechnology
Investment portfolio details for Linus Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Linus Biotechnology
Detailed financials for Linus Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Linus Biotechnology Comparisons
Peer comparison for Linus Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Linus Biotechnology
Linus Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genomics, Depixus, Seven Bridges Genomics, Ingenuity Systems and BC Platforms, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Platforms for genomic data analysis and management are provided.
|
|
| Locked | Locked | Locked |
Machine learning is utilized for precision medicine and genetic diagnostics.
|
Detailed competitors of Linus Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Linus Biotechnology
Complete news archive for Linus Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linus Biotechnology
Linus Biotechnology was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Linus Biotechnology is headquartered in New York, United States. It is registered at New York, New York, United States.
Linus Biotechnology is a funded company, having raised a total of $47.65M across 4 funding rounds to date.
Developer of diagnostic tests for central nervous system and gastrointestinal disorders. The company offers StrandDx ASD, a non-invasive diagnostic aid for Autism Spectrum Disorder. The companys pipeline comprises precision exposome medicine biomarkers and target discovery across gastroenterology, renal disease and oncology.
Linus Biotechnology's top competitors include Depixus, Ingenuity Systems and Envisagenics.
Linus Biotechnology has 5 investors. Key investors include Yac, GreatPoint Ventures, BowX Acquisition Corp, Divergent Investments, and Nicole Shanahan.